Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis - Takeaways - MDSpire

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

  • By

  • Ning Li

  • Jitao Zhang

  • Yongyan Wang

  • Yugeng Li

  • May 28, 2026

  • 0 min

Share

  • 1

    Cardiovascular disease is the leading cause of morbidity and mortality in diabetes mellitus, necessitating early detection methods.

  • 2

    Cardiac magnetic resonance imaging biomarkers, including ECV and perfusion indices, show promise for identifying cardiovascular complications in diabetes.

  • 3

    Nineteen studies involving over 3,900 patients demonstrated significant myocardial changes in diabetic patients using CMR techniques.

  • 4

    Meta-analysis revealed elevated ECV, reduced myocardial perfusion reserve index, and increased prevalence of late gadolinium enhancement in diabetes.

  • 5

    Further large-scale, standardized trials are needed to confirm the role of CMR biomarkers in early detection and risk stratification for cardiovascular issues.

Original Source(s)

Related Content